Survey: Eco-conscious habits can begin with tampon brand purchases
SKILLMAN, N.J. A recent survey commissioned by O.B. tampons found that 10% of women currently use non-applicator tampons as a way to reduce waste. Almost two-thirds of women (64%) have never thought about the environmental waste produced by the tampons they use, the survey, which was released Monday, found.
To help reduce waste, 35% of women would rather switch to a non-applicator tampon than cut the number of beauty products they use in half.
The O.B.-commissioned survey was conducted online by Kelton, comprised of 1,017 adults nationwide between Feb. 18 and Feb. 23.
Bausch & Lomb launches new PreserVision product
MADISON, N.J. Bausch & Lomb on Friday announced the U.S. launch of PreserVision eye vitamin and mineral supplement AREDS 2 formula.
The new formula builds on the original, clinically proven age-related eye disease study formula, replacing beta-carotene with lutein (10 mg) and zeaxanthin (2 mg) and adding omega-3 fatty acids (1,000 mg) per daily dosage. The product will be on retail shelves in early May, 2010, the eye care company stated.
Scientific studies show that the inclusion of high levels of omega-3 fatty acids, lutein and zeaxanthin in the diet supports eye health. Age-related macular degeneration is the leading cause of severe vision loss and blindness in the United States for people older than the age of 50 years.
The AREDS2 study, which is currently ongoing and expected to complete in 2013, is sponsored by the National Eye Institute/National Institute of Health and is the second nationwide clinical study to determine whether a combination of vitamins and minerals can further slow the progression of vision loss from AMD. PreserVision AREDS 2 formula is one of many formulas that are being evaluated in this study.
Senatorial caucus to discuss prescription-only status of PSE
WASHINGTON The Senate Caucus on International Narcotics Control will hold a hearing on “The Status of Meth: Oregon’s Experience Making Pseudoephedrine Prescription Only” on April 12 at 10 a.m. at the Dirksen Senate Office Building.
According to a report to be published that Monday in The Washington Daybook, scheduled participants include: Sen. Dianne Feinstein, D-Calif., chair of the Caucus on International Narcotics Control; Sen. Ron Wyden, D-Ore.; Gil Kerlikowske, director of the Office of National Drug Control Policy; Charles Ganley, director of the Office of Nonprescription Drug Products in the Food and Drug Administration’s Center for Drug Evaluation and Research; Keith Cain, sheriff of Davies County, Ky.; Oregon Attorney General John Kroger; Linda Suydam, president of the Consumer Healthcare Products Association; and Kent Shaw, assistant chief of the California Bureau of Narcotics Enforcement.
Sens. Charles Grassley, R-Iowa, and Jeff Sessions, R-Ala., also are members of the C.I.N.C.